ClinicalTrials.gg
Sign In

Demyelinating Diseases clinical trials

The registry lists 103 studies for Demyelinating Diseases across more than 10 countries. 25 are recruiting or about to start. 11 of them are mainly about Demyelinating Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 14 narrower conditions too, such as Multiple Sclerosis: 4,165 studies, 857 open.

Get an email when these change. Save the Demyelinating Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
49
Recruiting
16
Terminated
11
Status unknown
9
Not yet recruiting
7
Withdrawn
4

Phase

Phase 2
22
Phase 1
16
Phase 3
14
Phase 4
3
Early Phase 1
3

Where

United States
53
Canada
19
Germany
16
France
15
Spain
12
Italy
11

Who runs them

National Institute of Neurological Disorders and Stroke (NINDS) (6) · Alexion Pharmaceuticals, Inc. (4) · Acorda Therapeutics (4) · Xuanwu Hospital, Beijing (3) · Novartis Pharmaceuticals (3) · University of Texas at Austin (2) · Holy Name Medical Center, Inc. (2) · SwanBio Therapeutics, Inc. (2)

What is being tested here

Drugs under test in Demyelinating Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rituximab112
Clemastine101
Natalizumab101
4-Aminopyridine044
Eculizumab033
CNM-Au8012
Immunoglobulin G012
Cholecalciferol002
Ravulizumab011
PIPE-791001

Coming up

1phase 3 study under way
12studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 16 Demyelinating Diseases studies recruiting now, 5 (31%) set no upper age limit and 8 (50%) stop at 75 or younger. 1 (6%) take children under 18. 1 (6%) are for women only and 0 (0%) for men only; 2 (13%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
101 (6%)1 (6%)
1815 (94%)14 (88%)
3015 (94%)14 (88%)
4015 (94%)14 (88%)
5016 (100%)15 (94%)
6515 (94%)14 (88%)
758 (50%)7 (44%)
856 (38%)5 (31%)

Across all 103 studies, recruiting or not: 60% stop at 75 or younger and 52% at 65; 21% take children; 2% are for women only and 3% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 103. Browse all 103 → or search them.